SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Neogen Corp. – ‘8-K’ for 3/2/21 – ‘EX-99.1’

On:  Tuesday, 3/2/21, at 5:18pm ET   ·   For:  3/2/21   ·   Accession #:  1193125-21-65747   ·   File #:  0-17988

Previous ‘8-K’:  ‘8-K’ on 1/7/21 for 1/4/21   ·   Next:  ‘8-K’ on / for 3/23/21   ·   Latest:  ‘8-K’ on / for 4/9/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/02/21  Neogen Corp.                      8-K:5,9     3/02/21   11:133K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     24K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      8K 
 7: R1          Document and Entity Information                     HTML     41K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- d114694d8k_htm                      XML     12K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- neog-20210302_lab                     XML     47K 
 5: EX-101.PRE  XBRL Presentations -- neog-20210302_pre              XML     30K 
 3: EX-101.SCH  XBRL Schema -- neog-20210302                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               10±    17K 
11: ZIP         XBRL Zipped Folder -- 0001193125-21-065747-xbrl      Zip     10K 


‘EX-99.1’   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-99.1  

Exhibit 99.1

FOR IMMEDIATE RELEASE

 

CONTACT:    Steve Quinlan, Chief Financial Officer
   Neogen Corporation, 517/372-9200

Papesh retires from Neogen’s Board after 27 years

LANSING, Mich., March 2, 2021 — Neogen Corporation (NASDAQ: NEOG) announced today that long-serving G. Bruce Papesh has retired from Neogen’s Board of Directors.

Papesh joined Neogen’s Board in October 1993, and has helped guide the company from approximately $8 million in annual revenues to approximately $418 million in revenues in its most recently completed fiscal year (May 31).

“Everyone who has benefitted from Neogen’s success, including those in the investment community and all of the company’s employees for the past 27 years, owes a debt of gratitude to Bruce Papesh,” said James Borel, chairman of Neogen’s Board of Directors. “His investment background and financial experience and expertise was critical to Neogen as the company struggled to survive back in its early days, and he has continued to serve Neogen well over the years as we have worked to expand upon our success. We will miss Bruce’s insight on the Board, and thank him for his many years of exemplary service to the company.”

From 1987 to 2020, Papesh served as president of Dart, Papesh & Company, Inc., which until 2019 was a SIPC and FINRA member and an investment consulting and financial services firm.

With Papesh’s retirement, Neogen’s Board now consists of: Borel, John Adent, Dr. William Boehm, Dr. Ronald Green, James Tobin, Ralph Rodriguez, Darci Vetter, and Dr. Catherine Woteki.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

###


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/2/21None on these Dates
 List all Filings 
Top
Filing Submission 0001193125-21-065747   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 6:31:34.2pm ET